ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.22M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$146.03
Trade value
$1.39M
% of position
Common Stock
Shares
−82.00
Price / share
$542.98
Trade value
$44.52K
% of position
Common Stock
Shares
−51.00
Price / share
$543.61
Trade value
$27.72K
% of position
Common Stock
Shares
−576.00
Price / share
$545.00
Trade value
$313.92K
% of position
Common Stock
Shares
−31.00
Price / share
$545.55
Trade value
$16.91K
% of position
Common Stock
Shares
−159.00
Price / share
$547.25
Trade value
$87.01K
% of position
Common Stock
Shares
−2.01K
Price / share
$548.09
Trade value
$1.10M
% of position
Common Stock
Shares
−1.94K
Price / share
$549.21
Trade value
$1.06M
% of position
Common Stock
Shares
−2.94K
Price / share
$550.07
Trade value
$1.62M
% of position
Common Stock
Shares
−1.40K
Price / share
$551.15
Trade value
$771.60K
% of position
Common Stock
Shares
−320.00
Price / share
$551.87
Trade value
$176.60K
% of position
Net shares
+0.00
Net value
-$3.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | M · Option Exercise | +9.50K | $146.03 | $1.39M | 23.4% | 40.51K | 50.01K |
| Common Stock Direct | 6/11/2026 | S · Sale | −82.00 | $542.98 | $44.52K | 0.2% | 50.01K | 49.93K |
| Common Stock Direct | 6/11/2026 | S · Sale | −51.00 | $543.61 | $27.72K | 0.1% | 49.93K | 49.88K |
| Common Stock Direct | 6/11/2026 | S · Sale | −576.00 | $545.00 | $313.92K | 1.2% | 49.88K | 49.30K |
| Common Stock Direct | 6/11/2026 | S · Sale | −31.00 | $545.55 | $16.91K | 0.1% | 49.30K | 49.27K |
| Common Stock Direct | 6/11/2026 | S · Sale | −159.00 | $547.25 | $87.01K | 0.3% | 49.27K | 49.11K |
| Common Stock Direct | 6/11/2026 | S · Sale | −2.01K | $548.09 | $1.10M | 4.1% | 49.11K | 47.11K |
| Common Stock Direct | 6/11/2026 | S · Sale | −1.94K | $549.21 | $1.06M | 4.1% | 47.11K | 45.17K |
| Common Stock Direct | 6/11/2026 | S · Sale | −2.94K | $550.07 | $1.62M | 6.5% | 45.17K | 42.23K |
| Common Stock Direct | 6/11/2026 | S · Sale | −1.40K | $551.15 | $771.60K | 3.3% | 42.23K | 40.83K |
| Common Stock Direct | 6/11/2026 | S · Sale | −320.00 | $551.87 | $176.60K | 0.8% | 40.83K | 40.51K |
| Total | +0.00 | -$3.83M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
146.03
Held after
50.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock9.50K shares | 6/11/2026 | M · Option Exercise | −9.50K | 146.03 | — | 50.41K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 324.44K | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 628.22K | 628.22K indirect |